Skip to main content
Equibles

Creative Planning

Position in PCRX — Pacira BioSciences, Inc.

CIK 1540235 OVERLAND PARK, KS
Back to PCRX Full portfolio

Position in PCRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$876,989
+$263,332 QoQ
Shares Held
34,568
+27.3% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#97
of 254 holders
Holding Since
Mar 2023
11 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Creative Planning holds $137,414,626 across 41 Drug Manufacturers - Specialty & Generic names. PCRX ranks #23 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RDY
Dr Reddys Laboratories Ltd
 1,240,848 $17,979,887
2 UTHR
UNITED THERAPEUTICS Corp
 28,934 $15,677,309
3 VTRS
Viatris Inc
 920,607 $14,619,238
4 NBIX
Neurocrine Biosciences Inc
 76,818 $12,946,905
5 LNTH
Lantheus Holdings, Inc.
 85,571 $9,493,246
6 TAK
Takeda Pharmaceutical Co Ltd
 584,777 $9,373,974
7 ZTS
Zoetis Inc.
 121,209 $8,710,078
8 HIMS
Hims & Hers Health, Inc.
 225,206 $7,807,891

All Filings in PCRX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $876,989 34,568
2026-03-31 $613,657 27,153
2025-12-31 $891,902 34,463
2025-09-30 $657,779 25,525
2025-06-30 $615,304 25,745
2025-03-31 $673,658 27,109
2024-12-31 $464,330 24,646
2024-09-30 $241,838 16,069
2024-06-30 $236,718 8,274
2023-09-30 $1,902 62
2023-03-31 $204 5